BG104910A - Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament - Google Patents
Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicamentInfo
- Publication number
- BG104910A BG104910A BG104910A BG10491000A BG104910A BG 104910 A BG104910 A BG 104910A BG 104910 A BG104910 A BG 104910A BG 10491000 A BG10491000 A BG 10491000A BG 104910 A BG104910 A BG 104910A
- Authority
- BG
- Bulgaria
- Prior art keywords
- asthmatic
- neuro
- immuno
- modulating
- ones
- Prior art date
Links
- -1 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones Chemical class 0.000 title abstract 2
- 230000003266 anti-allergic effect Effects 0.000 title abstract 2
- 230000001088 anti-asthma Effects 0.000 title abstract 2
- 239000000924 antiasthmatic agent Substances 0.000 title abstract 2
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 2
- 230000000324 neuroprotective effect Effects 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19821003A DE19821003A1 (de) | 1998-05-11 | 1998-05-11 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PCT/EP1999/002291 WO1999058504A1 (de) | 1998-05-11 | 1999-04-01 | Neue 1,2,5-trisubstituierte 1,2-dihydro-indazol-3-one mit antiasthmatischer, antiallergischer, entzündungshemmender, immunmodulierender und neuroprotektiver wirkung, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG104910A true BG104910A (en) | 2001-06-29 |
Family
ID=7867363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG104910A BG104910A (en) | 1998-05-11 | 2000-11-03 | Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6180637B1 (xx) |
| EP (1) | EP1077948A1 (xx) |
| JP (1) | JP2002514627A (xx) |
| KR (1) | KR20010025011A (xx) |
| CN (1) | CN1309642A (xx) |
| AR (1) | AR018605A1 (xx) |
| AU (1) | AU745796B2 (xx) |
| BG (1) | BG104910A (xx) |
| BR (1) | BR9911772A (xx) |
| CA (1) | CA2271837A1 (xx) |
| CO (1) | CO5021131A1 (xx) |
| DE (1) | DE19821003A1 (xx) |
| HK (1) | HK1038751A1 (xx) |
| HU (1) | HUP0101707A3 (xx) |
| IL (1) | IL139358A0 (xx) |
| NO (1) | NO20005698L (xx) |
| NZ (1) | NZ508646A (xx) |
| PL (1) | PL344254A1 (xx) |
| SK (1) | SK17082000A3 (xx) |
| TR (1) | TR200003302T2 (xx) |
| TW (1) | TW448163B (xx) |
| WO (1) | WO1999058504A1 (xx) |
| ZA (1) | ZA200006151B (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
| US6417189B1 (en) * | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
| WO2008141385A1 (en) * | 2007-05-21 | 2008-11-27 | Biota Scientific Management Pty Ltd | Viral polymerase inhibitors |
| PE20140976A1 (es) | 2011-03-14 | 2014-08-28 | Boehringer Ingelheim Int | Inhibidores de benzodioxano de la producion de leucotrieno |
| WO2013012844A1 (en) | 2011-07-19 | 2013-01-24 | Boehringer Ingelheim International Gmbh | Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| WO2013134226A1 (en) | 2012-03-06 | 2013-09-12 | Boehringer Ingelheim International Gmbh | Benzodioxanes for inhibiting leukotriene production |
| AR090259A1 (es) | 2012-03-06 | 2014-10-29 | Boehringer Ingelheim Int | Inhibidores de benzodioxano de la produccion de leucotrieno para terapia de combinacion |
| TW201416354A (zh) | 2012-07-17 | 2014-05-01 | Boehringer Ingelheim Int | 白三烯生成抑制劑 |
| EP3022194B1 (en) | 2013-07-15 | 2017-05-17 | Boehringer Ingelheim International GmbH | Inhibitors of leukotriene production |
| WO2015009609A1 (en) | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Inhibitors of leukotriene production |
| NZ749389A (en) * | 2016-06-08 | 2022-12-23 | Sunregen Healthcare Ag | Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement |
| CN113105409B (zh) * | 2021-04-06 | 2023-06-02 | 四川大学 | 2-(羟基苄基)苯并[d]异噻唑酮类化合物、其制备方法和用途 |
| CA3221177A1 (en) | 2021-11-01 | 2023-05-04 | Meghan Kerrisk Campbell | Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3132916A1 (de) * | 1981-08-20 | 1983-03-03 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 1-phenylindazol-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| US5179112A (en) * | 1985-04-17 | 1993-01-12 | Ici Americas Inc. | Heterocyclic amide derivatives and pharmaceutical use |
| IL84944A (en) * | 1987-01-19 | 1992-02-16 | Ici Plc | Pharmaceutical compositions containing 1,2-dihydro-3h-indazolone derivatives,some new such compounds and their preparation |
| US5036083A (en) * | 1988-07-15 | 1991-07-30 | Ici Pharma | Heterocyclic agents |
| US5229408A (en) * | 1988-07-15 | 1993-07-20 | Ici Pharma | 4-carbamoyl-1,2-dihydro-3H-indazol-3-one derivatives |
| DE19610882A1 (de) * | 1996-03-20 | 1997-09-25 | Dresden Arzneimittel | Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
1998
- 1998-05-11 DE DE19821003A patent/DE19821003A1/de not_active Withdrawn
-
1999
- 1999-04-01 SK SK1708-2000A patent/SK17082000A3/sk unknown
- 1999-04-01 NZ NZ508646A patent/NZ508646A/xx unknown
- 1999-04-01 TR TR2000/03302T patent/TR200003302T2/xx unknown
- 1999-04-01 IL IL13935899A patent/IL139358A0/xx unknown
- 1999-04-01 HK HK02100376.2A patent/HK1038751A1/zh unknown
- 1999-04-01 AU AU42576/99A patent/AU745796B2/en not_active Ceased
- 1999-04-01 JP JP2000548308A patent/JP2002514627A/ja active Pending
- 1999-04-01 CN CN99808515A patent/CN1309642A/zh active Pending
- 1999-04-01 PL PL99344254A patent/PL344254A1/xx unknown
- 1999-04-01 EP EP99950343A patent/EP1077948A1/de not_active Withdrawn
- 1999-04-01 WO PCT/EP1999/002291 patent/WO1999058504A1/de not_active Ceased
- 1999-04-01 KR KR1020007012614A patent/KR20010025011A/ko not_active Withdrawn
- 1999-04-01 BR BR9911772-0A patent/BR9911772A/pt not_active IP Right Cessation
- 1999-04-01 HU HU0101707A patent/HUP0101707A3/hu unknown
- 1999-04-23 TW TW088106565A patent/TW448163B/zh not_active IP Right Cessation
- 1999-05-05 US US09/305,602 patent/US6180637B1/en not_active Expired - Fee Related
- 1999-05-07 CO CO99028290A patent/CO5021131A1/es unknown
- 1999-05-11 CA CA002271837A patent/CA2271837A1/en not_active Abandoned
- 1999-05-11 AR ARP990102212A patent/AR018605A1/es not_active Application Discontinuation
-
2000
- 2000-10-31 ZA ZA200006151A patent/ZA200006151B/en unknown
- 2000-11-03 BG BG104910A patent/BG104910A/xx unknown
- 2000-11-10 NO NO20005698A patent/NO20005698L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9911772A (pt) | 2001-02-06 |
| CO5021131A1 (es) | 2001-03-27 |
| AR018605A1 (es) | 2001-11-28 |
| US6180637B1 (en) | 2001-01-30 |
| EP1077948A1 (de) | 2001-02-28 |
| NZ508646A (en) | 2002-11-26 |
| NO20005698D0 (no) | 2000-11-10 |
| TR200003302T2 (tr) | 2001-02-21 |
| HK1038751A1 (zh) | 2002-03-28 |
| DE19821003A1 (de) | 1999-11-18 |
| AU4257699A (en) | 1999-11-29 |
| CA2271837A1 (en) | 1999-11-11 |
| ZA200006151B (en) | 2000-12-06 |
| HUP0101707A3 (en) | 2002-06-28 |
| TW448163B (en) | 2001-08-01 |
| WO1999058504A1 (de) | 1999-11-18 |
| KR20010025011A (ko) | 2001-03-26 |
| NO20005698L (no) | 2001-01-08 |
| SK17082000A3 (sk) | 2001-09-11 |
| PL344254A1 (en) | 2001-10-22 |
| WO1999058504A9 (de) | 2000-02-03 |
| IL139358A0 (en) | 2001-11-25 |
| CN1309642A (zh) | 2001-08-22 |
| HUP0101707A2 (hu) | 2002-03-28 |
| AU745796B2 (en) | 2002-03-28 |
| JP2002514627A (ja) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG104812A (en) | New dihydropyrimidines | |
| GEP20053488B (en) | Novel Spiro Compounds | |
| CA2262566A1 (en) | Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect | |
| MX9601069A (es) | Nuevas pirido /3,2-e/pirazinonas con efecto antiasmatico y procedimiento para su preparacion. | |
| BG104910A (en) | Novel 1,2,5-trisubstituted 1,2-dihydroindazol-3-ones with anti-asthmatic, antiallergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament | |
| WO2001045678A3 (de) | Arzneimittel, verfahren zu dessen herstellung und dessen verwendung | |
| IL144370A0 (en) | Epothilon derivatives, method for the production and the use thereof as pharmaceuticals | |
| HUP9901616A3 (en) | Novel benzofuranone derivatives, process for their production and pharmaceutical compositions of the same | |
| IL139359A0 (en) | Novel 1,5-and 3-0-substituted 1h-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as medicaments | |
| AU3156600A (en) | Novel epothilon derivatives, method for the production thereof and their pharmaceutical application | |
| WO1999054315A3 (de) | Triazolone mit neuroprotektiver wirkung | |
| WO2001049654A3 (de) | Substituierte aminomethyl-phenyl-cyclohexanderivate | |
| YU12000A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
| HUP0104002A3 (en) | Alpha2-antagonists tricyclic delta3-piperidines, process for their producing the pharmaceutical compositions containing them and their use as medicament | |
| AU2011501A (en) | Benzimidazoles, production thereof and the use thereof as antithrombotic | |
| WO2004022542A3 (de) | Substituierte 1,2,3,4-tetrahydrochinolinderivate | |
| AU2001260110A1 (en) | Novel LHRH-antagonists, Production and Use Thereof as Medicament | |
| AU2003241785A1 (en) | Intravenous composition, process for producing the same and preparation thereof | |
| PL356523A1 (en) | Substituted 1 and 2 naphthol mannich bases | |
| WO2000017176A3 (de) | Benzolylguanidin-abkömmlinge mit vorteilhaften eigenschaften, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von arzneimiteln | |
| NZ513921A (en) | 1,3,4-oxadiazole derivatives and process for producing the same | |
| AU7773700A (en) | Method for the production or preparation of 2,6-dichlorotoluol | |
| DE50006244D1 (en) | Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine | |
| DE69627184D1 (de) | 3-aminoethyl-n-amidino-2,5-dihydropyrrol derivative mit arginine-mimetischen eigenschaften | |
| DE69903024D1 (de) | Thiocolchicosid-derivate, ihre herstellung und verwendung als arzneimittel |